<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28832799</article-id><article-id pub-id-type="pmc">5570393</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic
Valve Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chavez</surname><given-names>Ernesto Koehler</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Colafranceschi</surname><given-names>Alexandre Siciliano</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Monteiro</surname><given-names>Andrey Jos&#x000e9; de Oliveira</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Canale</surname><given-names>Leonardo Secchin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mesquita</surname><given-names>Evandro Tinoco</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Weksler</surname><given-names>Clara</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Odilon Nogueira</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Anderson</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ,
Brazil.</aff><aff id="aff2">
<label>2</label> Universidade Federal Fluminense (UFF), Niter&#x000f3;i, RJ,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Ernesto Koehler Chavez, Instituto Nacional
de Cardiologia - Cirurgia Cardiovascular, Rua Das Laranjeiras, 347 - Laranjeiras
- Rio de Janeiro, RJ, Brazil, Zip code: 22240-006. E-mail:
<email>ernestokchavez@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2017</year></pub-date><volume>32</volume><issue>3</issue><fpage>202</fpage><lpage>209</lpage><history><date date-type="received"><day>27</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To assess heart rhythm and predictive factors associated with sinus rhythm
after one year in patients with rheumatic valve disease undergoing
concomitant surgical treatment of atrial fibrillation. Operative mortality,
survival and occurrence of stroke after one year were also evaluated.</p></sec><sec><title>Methods</title><p>Retrospective longitudinal observational study of 103 patients undergoing
rheumatic mitral valve surgery and ablation of atrial fibrillation using
uni- or bipolar radiofrequency between January 2013 and December 2014. Age,
gender, functional class (NYHA), type of atrial fibrillation, EuroSCORE,
duration of atrial fibrillation, stroke, left atrial size, left ventricular
ejection fraction, cardiopulmonary bypass time, myocardial ischemia time and
type of radiofrequency were investigated.</p></sec><sec><title>Results</title><p>After one year, 66.3% of patients were in sinus rhythm. Sinus rhythm at
hospital discharge, lower left atrial size in the preoperative period and
bipolar radiofrequency were associated with a greater chance of sinus rhythm
after one year. Operative mortality was 7.7%. Survival rate after one year
was 92.3% and occurrence of stroke was 1%.</p></sec><sec><title>Conclusion</title><p>Atrial fibrillation ablation surgery with surgical approach of rheumatic
mitral valve resulted in 63.1% patients in sinus rhythm after one year.
Discharge from hospital in sinus rhythm was a predictor of maintenance of
this rhythm. Increased left atrium and use of unipolar radiofrequency were
associated with lower chance of sinus rhythm. Operative mortality rate of
7.7% and survival and stroke-free survival contribute to excellent care
results for this approach.</p></sec></abstract><kwd-group><kwd>Atrial Fibrillation</kwd><kwd>Ablation</kwd><kwd>Catheter Ablation</kwd><kwd>Rheumatic Disease</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AF</td><td align="left" rowspan="1" colspan="1">= Atrial fibrillation</td></tr><tr><td align="left" rowspan="1" colspan="1">AHA</td><td align="left" rowspan="1" colspan="1">= American Heart Association</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="left" rowspan="1" colspan="1">= Chronic obstructive pulmonary disease</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">LA</td><td align="left" rowspan="1" colspan="1">= Left atrium</td></tr><tr><td align="left" rowspan="1" colspan="1">LV</td><td align="left" rowspan="1" colspan="1">= Left ventricular</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA</td><td align="left" rowspan="1" colspan="1">= New York Heart Association Functional</td></tr><tr><td align="left" rowspan="1" colspan="1">SAH</td><td align="left" rowspan="1" colspan="1">= Systemic arterial hypertension</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Atrial fibrillation (AF) is the most common sustained arrhythmia in the United
States, where a prevalence of 2.2 million people with AF is estimated<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. The prevalence of AF increases with age. It is estimated that
the incidence of AF doubles for each decade of adult life. AF affects 2.3% of
individuals over 40 years and 5.9% of those over 65 years<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>Approximately 70% of individuals diagnosed with AF are between 65 and 80 years
old<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. In addition, it can
also be considered an important risk factor for stroke<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>AF is an independent risk factor for mortality, with relative risk for all ages of
1.5 for men and 1.9 for women<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>In the last 20 years, hospital admissions related to AF increased by 66%<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. In Brazil, AF is the
5<sup>th</sup> largest cause of hospitalization in the Unified Health System
(SUS - acronym in Portuguese) and affects 10% of the population served by the
specialized department of cardiology in hospitals with a level of complexity of
quaternary care<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>The high prevalence of this arrhythmia, the expenses with the health system and the
high morbidity and mortality associated with that disease have justified the search
for a better understanding of its pathophysiological bases and of new therapeutic
approaches<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>Despite being considered a benign disease, AF is associated with significant
morbidity and mortality due to three levels of sequelae:</p><p>
<list list-type="alpha-lower"><list-item><p>Discomfort and anxiety generated by irregular heartbeats;</p></list-item><list-item><p>Hemodynamic compromise due to loss of atrioventricular synchrony;</p></list-item><list-item><p>Blood stasis inside the left atrium, with greater vulnerability to
systemic thromboembolism.</p></list-item></list>
</p><p>AF may be related to thromboembolism and stroke in 5-10% of high-risk
patients<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. The risk
increases with age and the presence of concomitant structural heart disease.
According to the American Heart Association (AHA), it is estimated that more than
70,000 cases of stroke are related to AF each year.</p><p>Up to the present time, the Maze surgery is the gold standard in the surgical
treatment of AF, with success in healing AF greater than 90%<sup>[<xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r11" ref-type="bibr">11</xref>]</sup>. The mechanism by which the procedure is able to prevent
recurrence of AF is not yet conclusively established. However, the theory is that,
with surgery, conduction blocks are created in the right and left atria, preventing
macro-reentry circuits, responsible for the persistence of AF (<xref ref-type="fig" rid="f1">Figure 1</xref>)<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Atrial fibrillation (Reentry circuits). Adapted from Cox et
al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p></caption><graphic xlink:href="rbccv-32-03-0202-g01"/></fig>
</p><p>Maze surgery involves the creation of surgical incisions at strategic sites of both
atria which are then re-sutured by creating electrical conduction block lines that
prevent the formation and conduction of errant electrical impulses, driving the
electrical impulse generated at the sinus node to the atrioventricular node. Maze
surgery was designed to accomplish three objectives:</p><p>
<list list-type="bullet"><list-item><p>Stop all reentry circuits that can lead to the development and
maintenance of AF;</p></list-item><list-item><p>Restore control of the heart rate to the atrial pacing complex;</p></list-item><list-item><p>Allow the entire atrial myocardium to be activated to preserve the atrial
transport function.</p></list-item></list>
</p><p>Maze surgery, when performed, is often concomitant with other cardiac procedures such
as coronary artery bypass surgery, valve repair and/or replacement. Despite the
effectiveness of Maze surgery, its completion is still restricted due to its
morbidity related to the time required to perform the set of lesions, among others
factors. Surgical risk increases due to the high times required of cardiac anoxia
and CPB (cardiopulmonary bypass). Due to this, great effort is required to reduce
the morbidity associated with this procedure<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Recently, different sources of energy have been identified in order to reduce the
time and morbidity of surgical procedures for the treatment of AF<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. In the last 10
years, great advances have occurred in the development of different energy sources
capable of creating electric conduction blocks in myocardial tissue. The application
of endo- or epicardial radiofrequency is capable of producing myocardial necrosis
that electrically isolates myocardial tissue in a manner similar to that
demonstrated by classic Maze surgery (cutting and suturing)<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>The ideal set of lesions in the atrial myocardial tissue is not yet defined.
Isolation of the pulmonary veins and excision of the left atrium are mandatory and
seem to be associated with AF-free survival. Several methods including these
components have corrected AF in 70% to 90% of patients. The importance of connecting
lesions in the left atrium (e.g. between right and left pulmonary veins or left
pulmonary veins to the mitral annulus) is uncertain. Atrial fibrillation arising
from the right atrium is uncommon. Right atrial lesions are required only in
patients with typical atrial flutter. As a result, isolation of the pulmonary veins
combined with excision of the left atrium may represent the appropriate operation
for most AF patients. However, additional studies are needed to test this
hypothesis.</p><p>Records and retrospective analyzes have not shown an increase in surgical mortality
when intervention on the mitral valve is performed concomitantly with atrial
fibrillation ablation<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.
However, an increase in postoperative morbidity is observed<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>In Brazil, a large part of the population of patients in the Unified Health System
requiring surgical intervention on the mitral valve has a diagnosis of rheumatic
heart disease. In this clinical scenario, the impact of the use of bipolar
radiofrequency devices in the surgical treatment of atrial fibrillation in operative
mortality and in event-free survival is still to be defined<sup>[<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>The main objective included the evaluation of the cardiac rate at hospital discharge
and a one-year postoperative follow-up period as well as factors associated with the
occurrence of sinus rhythm at the end of the first year with patients presenting
rheumatic heart disease and indication for mitral valve surgery concomitant with
surgical ablation of atrial fibrillation.</p><p>The secondary aim of this study is to describe operative mortality and one-year
survival, as well as the incidence of stroke in the same period.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Observational, longitudinal and retrospective study. One hundred and three
consecutive patients undergoing mitral valve surgery of rheumatic etiology with
concomitant atrial fibrillation ablation using unipolar or bipolar radiofrequency
were evaluated. Patients undergoing associated tricuspid repair were included. All
patients were operated at the Instituto Nacional de Cardiologia (INC) between
January 2013 and December 2014.</p><p>Patients undergoing other associated procedures such as aortic valve replacement or
coronary artery bypass grafting were excluded. Reoperation procedures were also
excluded.</p><p>Study performed in a Brazilian public institution in which patients are cared for by
several surgical teams. Seven different surgeons participated in the surgical
interventions as the first operator.</p><p>In all patients, electrical isolation of the pulmonary veins was performed in pairs
(left and right). Atrial connection ablation lines (upper and/or lower) and the type
of device used for ablation (uni- or bipolar radiofrequency) were chosen according
to the preference of the main surgeon and the availability of the device at the
institution. The closure of the left atrial appendage was also performed at the
discretion of the surgeon, always through the endocardial route with continuous
suture with 3-0 or 4-0 Prolene.</p><p>The pre-, intra- and postoperative clinical and surgical variables investigated
were:</p><p>
<list list-type="order"><list-item><p>Age</p></list-item><list-item><p>Gender</p></list-item><list-item><p>Comorbidities: systemic arterial hypertension (SAH), diabetes, chronic
obstructive pulmonary disease (COPD) and smoking.</p></list-item><list-item><p>New York Heart Association Functional Class (NYHA) functional class</p></list-item><list-item><p>Type of AF: paroxysmal, persistent or permanent (American Heart
Association - AHA)</p></list-item><list-item><p>EuroSCORE</p></list-item><list-item><p>Time of fibrillation</p></list-item><list-item><p>Previous stroke</p></list-item><list-item><p>Left atrium (LA) size by echocardiography</p></list-item><list-item><p>Left ventricular (LV) ejection fraction by echocardiography</p></list-item><list-item><p>Cardiopulmonary bypass time</p></list-item><list-item><p>Time of myocardial ischemia</p></list-item></list>
</p><p>Ablation lines performed: isolation of the pulmonary veins in pairs; lesions in the
posterior wall of LA; connecting line to the mitral valve annulus; cavo-tricuspid
line (between the inferior vena cava ostium and the tricuspid valve annulus);
cava-cava line (between the ostia of both venae cavae) (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Lines of tissue lesion by radiofrequency in the left atrium. Adapted from
Weimar et al. <sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p></caption><graphic xlink:href="rbccv-32-03-0202-g02"/></fig>
</p><p>Patients were followed-up postoperatively with visits scheduled for 1 month, 6 months
and 12 months after surgery. During these visits, a non-blind investigator for the
offered treatment has evaluated heart rate, medication use, thromboembolic events,
need for percutaneous or surgical re-interventions.</p><p>The rhythm investigation was always performed with conventional CPB at each medical
appointment and with 24h Holter.</p><p>The criterion of therapeutic failure was that of any irregular tachyarrhythmia
lasting more than 30 seconds.</p><p>
<xref ref-type="table" rid="t1">Table 1</xref> shows the general characteristics of
the patients analyzed.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of the patients studied.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Age (years)</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Minimum</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">Maximum</td><td align="center" rowspan="1" colspan="1">72</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean &#x000b1; SD</td><td align="center" rowspan="1" colspan="1">50.76&#x000b1;10.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">78 (76%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">25 (24%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Comorbidities</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">SAH</td><td align="center" rowspan="1" colspan="1">42 (40.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">8 (7.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">21 (20.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous stroke</td><td align="center" rowspan="1" colspan="1">11 (10.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative definitive pacemaker</td><td align="center" rowspan="1" colspan="1">1 (0.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>NYHA Functional class</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Class 1</td><td align="center" rowspan="1" colspan="1">16 (15.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Class 2</td><td align="center" rowspan="1" colspan="1">63 (61.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Class 3</td><td align="center" rowspan="1" colspan="1">17 (18%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Class 4</td><td align="center" rowspan="1" colspan="1">7 (5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE (mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">4.99&#x000b1;2.06</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Type of AF</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Paroxysmal</td><td align="center" rowspan="1" colspan="1">13 (12%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Persistent</td><td align="center" rowspan="1" colspan="1">8 (8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Permanent&#x000a0;</td><td align="center" rowspan="1" colspan="1">82 (80%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous AF time ( mean &#x000b1; SD )</td><td align="center" rowspan="1" colspan="1">39.9&#x000b1;4.68&#x000a0; months</td></tr><tr><td align="left" rowspan="1" colspan="1">Left atrial size ( mean &#x000b1; SD )</td><td align="center" rowspan="1" colspan="1">5.6&#x000b1;0.8 cm</td></tr><tr><td align="left" rowspan="1" colspan="1">LV ejection fraction ( mean &#x000b1; SD )</td><td align="center" rowspan="1" colspan="1">58.34%&#x000b1;11.65 (Teichholtz )</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Medications</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Oral
anticoagulant&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">39.5%</td></tr><tr><td align="left" rowspan="1" colspan="1">LMWH</td><td align="center" rowspan="1" colspan="1">18.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">Beta-blockers</td><td align="center" rowspan="1" colspan="1">27.8%</td></tr><tr><td align="left" rowspan="1" colspan="1">Digitalis</td><td align="center" rowspan="1" colspan="1">23.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiarrhythmics</td><td align="center" rowspan="1" colspan="1">6.9%</td></tr><tr><td align="left" rowspan="1" colspan="1">Diuretics</td><td align="center" rowspan="1" colspan="1">65%</td></tr><tr><td align="left" rowspan="1" colspan="1">ACE inhibtor</td><td align="center" rowspan="1" colspan="1">23%</td></tr><tr><td align="left" rowspan="1" colspan="1">ARBs</td><td align="center" rowspan="1" colspan="1">6.9%</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>NYHA=New York Heart Association; AF=atrial fibrillation; LV=left
ventricle; cm=centimeter; LMWH = low molecular weight heparin; ACE =
angiotensin-converting enzyme; ARBs = angiotensin receptor blockers</p></fn></table-wrap-foot></table-wrap><p>The results are presented as mean &#x000b1; standard deviation for continuous
variables and percentage for categorical variables. The evaluation of the effect of
ablation surgery was performed using Student's t-test for the parametric data,
Chi-square and Wilcoxon tests for the others. Univariate and multivariate regression
analyzes were performed to evaluate predictive factors for AF recurrence. Survival
curves and event-free survival were constructed using the Kaplan Meyer method.
Values of probability less than 0.05 were considered statistically significant.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Surgeries performed are shown in <xref ref-type="fig" rid="f3">Figure 3</xref>.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Types of surgeries performed.</p><p>mec MVR=mechanical mitral valve replacement; De Vega= Tricuspid repair
using De Vega technique; bio MVR=Biological mitral valve replacement; TR
ring=Tricuspid repair with ring; MR ring=Mitral repair with ring;
TR=Tricuspid repair</p></caption><graphic xlink:href="rbccv-32-03-0202-g03"/></fig>
</p><p>The operative variables are listed in <xref ref-type="table" rid="t2">Table 2</xref>
and the ablation lines performed in <xref ref-type="fig" rid="f4">Figure
4</xref>:</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Perioperative data.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">CPB time (min)</th><th align="center" rowspan="1" colspan="1">125.47&#x000b1;30.52</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Myocardial ischemia time (min)</td><td align="center" rowspan="1" colspan="1">105.85&#x000b1;28.34</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of ablation</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Unipolar</td><td align="center" rowspan="1" colspan="1">20.19%</td></tr><tr><td align="left" rowspan="1" colspan="1">Bipolar</td><td align="center" rowspan="1" colspan="1">79.81%</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>CPB=cardiopulmonary bypass; Min=minutes</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Ablation lines performed. Results expressed in absolute numbers.</p><p>R=right; L=left; LA=left atrium</p></caption><graphic xlink:href="rbccv-32-03-0202-g04"/></fig>
</p><p>Eight (7.8%) patients died in the first 30 postoperative days and were considered as
procedure-related deaths. The causes of death in this period were: atrioventricular
disjunction in two patients, hemorrhagic shock in one patient, septic shock in two
patients, cardiogenic shock in two patients and cardiogenic shock associated with
adult respiratory distress syndrome in one patient. There were no deaths during the
one-year follow-up period of the patients who were discharged from the hospital.</p><p>The occurrence of a new stroke was 1%: one patient presented neurological event 17
days after surgery, who is still hospitalized. The heart rate, at the time of the
event, was the same as of AF. The symptomatology reversed completely in 7 days.
There were no other neurological events during the one-year follow-up period.</p><p>
<xref ref-type="fig" rid="f5">Figure 5</xref> shows the actuarial curve for
event-free survival (death and stroke) one year after surgery.</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Actuarial curve for event-free survival (stroke and death).</p></caption><graphic xlink:href="rbccv-32-03-0202-g05"/></fig>
</p><p>All survivors were followed-up for at least one year. At the time of hospital
discharge information on heart rate was present in the medical records of the 95
(100%) surviving patients. Among them, 70 (73.7%) patients were in sinus rhythm, 22
(23.1%) patients in the rhythm of AF and 3 (3.1%) patients in pacemaker rhythm, one
of whom already had a definitive pacemaker before surgery (<xref ref-type="fig" rid="f6">Figure 6</xref>). Two (2%) patients required a definitive new pacemaker
in the immediate postoperative period.</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Cardiac rate at discharge and at the end of the 1-year postoperative
follow-up period.</p></caption><graphic xlink:href="rbccv-32-03-0202-g06"/></fig>
</p><p>The one-year follow-up was performed in 100% of them (95 patients). A total of 388
electrocardiograms were analyzed in the postoperative follow-up period (3.3
electrocardiograms per patient) and 81 3-channels 24 hours Holter (0.8
Holter/patient). At the end of the one-year-follow-up period, 60 (63.1%) patients
were in sinus rhythm, 18 (18.9%) patients were in AF, 10 (10.5%) were in right
atrial flutter and pacemaker rhythm was present in 7 (7.3%). <xref ref-type="fig" rid="f7">Figure 7</xref> shows the actuarial AF-free survival curve of this
population in the first year of the follow-up period. <xref ref-type="fig" rid="f6">Figure 6</xref> compares the prevalence of sinus and non-sinus rhythm between
the time of hospital discharge and the end of the one-year-follow-up period.</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Actuarial curve for AF-free survival.</p></caption><graphic xlink:href="rbccv-32-03-0202-g07"/></fig>
</p><p>In the multivariate analysis by binary logistic regression, three variables were
associated with the occurrence of sinus rhythm during the one-year-follow-up period:
sinus rhythm at discharge, left atrium size and use of a tissue ablation device by
bipolar radiofrequency (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Multivariate analysis for sinus rhythm reversion one year after surgery.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables in the model</th><th align="center" rowspan="2" colspan="1">&#x003b2;</th><th align="center" rowspan="1" colspan="1">Standardized coefficient</th><th align="center" colspan="2" rowspan="1">95% Confidence Interval for the
Settlement Ratio (SR)</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower limit</th><th align="center" rowspan="1" colspan="1">SR</th><th align="center" rowspan="1" colspan="1">Upper limit</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Constant</td><td align="center" rowspan="1" colspan="1">6.758</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Sinus rhythm on discharge<xref ref-type="table-fn" rid="TFN4">**</xref></td><td align="center" rowspan="1" colspan="1">-3.381</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.034</td><td align="center" rowspan="1" colspan="1">0.142</td></tr><tr><td align="left" rowspan="1" colspan="1">Size of the left atrium<xref ref-type="table-fn" rid="TFN5">+</xref></td><td align="center" rowspan="1" colspan="1">-0.840</td><td align="center" rowspan="1" colspan="1">0.209</td><td align="center" rowspan="1" colspan="1">0.432</td><td align="center" rowspan="1" colspan="1">0.803</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of ablation<xref ref-type="table-fn" rid="TFN3">1</xref><xref ref-type="table-fn" rid="TFN6">***</xref></td><td align="center" rowspan="1" colspan="1">-2.079</td><td align="center" rowspan="1" colspan="1">0.032</td><td align="center" rowspan="1" colspan="1">0.125</td><td align="center" rowspan="1" colspan="1">0.483</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>1</label><p>Unipolar and Bipolar. R squared=0.494; </p></fn><fn id="TFN4"><label>**</label><p><italic>P</italic>&#x0003c;0.001; </p></fn><fn id="TFN5"><label>+</label><p><italic>P</italic>=0.003;</p></fn><fn id="TFN6"><label>***</label><p><italic>P</italic> = 0.024. </p></fn></table-wrap-foot></table-wrap><p>Sinus rhythm at discharge increases by 29 times the chance of remaining in sinus
rhythm in one year. The smaller the left atrium size the greater the chance of
remaining in sinus rhythm in one year (2.3 times). The use of a tissue ablation
device by bipolar radiofrequency increases this chance by eight times, when compared
to the use of unipolar radiofrequency.</p><p>As left atrial size was the only continuous variable related to the chance of being
or not in sinus rhythm in the 1-year follow-up period of these patients, the ROC
curve was evaluated to try to define the most accurate left atrial size for
determining the chance of being or not in sinus rhythm at the end of the one-year
follow-up period of this population.</p><p>The cut-off point of left atrium size performed through efficiency was 5.35 cm.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The pathophysiological mechanism of atrial fibrillation is not fully understood. The
predominant 20<sup>th</sup> century concept of multiple and chaotic atrial re-entry
circuits following variant lines of conduction block was challenged by the
observation that in some patients without structural heart disease the arrhythmia
could only arise from a defined focus (generally emerging from the pulmonary
veins)<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. The two
concepts seem to explain different forms of AF, the latter probably accounting for
up to 80% of cases of paroxysmal AF in structurally normal hearts<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. However, as the disease
progresses, the atria grow and become more fibrous. AF outbreaks can then multiply
and any treatment becomes less effective. Similarly, AF associated with mitral
disease is associated with volume or pressure overload in the left atrium making it
the main substrate of the arrhythmia. In cases of rheumatic disease<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> the chronic inflammatory process
itself may be responsible for the development of atrial fibrosis, even in the
absence of valve dysfunction.</p><p>The curative ablation of AF has two mechanistic objectives: a) to remove all the
triggers that could initiate or perpetuate the arrhythmia; b) alter the conduction
properties of the atria so that AF cannot be sustained even if initiated. Only two
approaches can modify the atrial substrate<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. The first, through the creation of linear transmural
lesions that connect two anatomical structures and form a conduction block
(interrupting the re-entry circuits that perpetuate the arrhythmia). The second
approach would involve reducing the amount of viable tissue<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. The possible disadvantage of
this approach would be the reduction of the potential of atrial
contractility<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p><p>The clinical objectives of performing an ablation of AF are to reduce or abolish
symptoms (palpitation or symptoms of heart failure), to improve left ventricular
function by restoring electrical and mechanical atrial systole, and ultimately to
reduce the risk of stroke).</p><p>Cox Maze III surgery, developed in 1992, after long experiments on canine
models<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, has proven
highly effective in addressing both the theoretical pathological mechanisms of
arrhythmia described above and in achieving the clinical objectives of rate control
(85% to 97% of long-term sinus rhythm)<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> and prevention of stroke (incidence of 0.3% in 12
years<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>). Cutting and
suturing biatrial lesions were performed by isolating the pulmonary veins,
communicating with the mitral ring and venous sinus, in addition to several lesions
in the right atrium. The major limitation of this method was its complexity and time
for execution since all the lesions were performed by cutting and suturing method.
Its diffusion in the surgical environment was always very limited. The advent of new
forms of energy that could recreate transmural lesions safely, effectively, and
rapidly led to a greater applicability of the method in several countries. Bipolar
radiofrequency is released by a clamp that envelopes the endocardial tissue into the
epicardium and has the ability to detect the moment the lesion becomes
transmural<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. The
unipolar radiofrequency is released by a pen-like instrument and must be applied in
the endocardium point-by-point. This instrument does not have the ability to detect
the transmurality of the lesion.</p><p>The use of these methods of surgical ablation in Brazil is still very limited when
compared to official data from the Thoracic Surgery Society (STS) of North
America<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. Between 2005
and 2010 more than 85,000 surgical ablations were performed associated with main
cardiac surgery and another 5,000 isolated ablations. About 40% of AF patients who
underwent cardiac surgery received some form of ablation. We do not yet have data
from the Brazilian practice.</p><p>In this study, we chose to study a homogeneous group of patients with mitral disease
of rheumatic origin. Most of them (82%) presented functional tricuspid insufficiency
with need for associated tricuspid repair. About 80% of the individuals presented
the permanent form of the arrhythmia and the mean size of the left atrium was 5.5
cm. All these characteristics lead us to the conclusion that this population had
advanced cardiac structural disease, which increases surgical risk, impedes
perioperative care and decreases the chance of successful atrial fibrillation
ablation, as discussed above.</p><p>The mean surgical risk estimated by the EuroSCORE standard places this population in
an intermediate risk zone for high risk. Therefore, in percentage numbers, the risk
of death in 30 days for this population between 5 and 10% can be inferred. The
occurrence of 8 (7.8%) deaths during the 30-day postoperative period seems to be
within the confidence interval expected by this surgical risk calculation tool,
inferring that there was no negative impact of completion of concomitant surgical
ablation in the operative mortality in this population. In a meta-analysis of
randomized controlled trials, used to evaluate the surgical treatment of
fibrillation in cardiac surgery performed by Phan et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> no significant difference between surgical
ablation <italic>versus</italic> non-ablation in terms of mortality was observed
(OR, 1.05, 95% CI 0.66 to 1.68, <italic>P</italic>=0.83) and neurological events
(OR, 0.86, 95% CI 0.37 to 2.04, <italic>P</italic>=0.74).</p><p>The 1-year mortality found in our study was 7.8%. It is noteworthy that all patients
died within the 30-day postoperative period. In a recent multicenter, randomized
study by Gillinov et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>,
where patients with permanent AF undergoing mitral valve surgery concomitant to
ablation were analyzed, no significant difference in the one-year mortality was
observed between the mitral valve ablation group (6.8%) and the control group of
isolated mitral surgery (8.7%) (<italic>P</italic>=0.57).</p><p>In our study, the occurrence of stroke before surgery was 10.6% (11 patients) and
after the 1-year follow-up period was 1.15% (1 patient). The study by Gillinov et
al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup> shows the
occurrence of 3% of stroke one year after the surgical procedure.</p><p>Our analysis also showed impact of left atrial size and occurrence of sinus rhythm in
1 year which correlates with the descriptions in the literature. The rate of sinus
rhythm patients after surgical ablation of AF at hospital discharge of 73% and, 63%
during the 1-year follow-up period, is compatible with the current series reported
in rheumatic patients<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p><p>In our series, an interesting non-significant difference in sinus rhythm was found
one year after surgery when bipolar (65%) and unipolar (40%) energy were used
(<italic>P</italic>=0.07). In the multivariate analysis, however, the use of
tissue ablation devices by bipolar radiofrequency was associated with an 8-fold
greater chance of being in sinus rhythm one after the procedure. The results
associated with the use of uni- or bipolar radiofrequency for surgical ablation of
AF are conflicting in the literature: Chen et al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> in a recent series of 324 patients undergoing
cardiac surgery for rheumatic valve disease (mitral, aortic and tricuspid) with
concomitant AF ablation using bipolar tweezers found sinus rhythm in 87% of patients
after the 1-year follow-up period. On the other hand, Pinho-Gomes et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup> in a mixed series of patients
undergoing mitral surgery of rheumatic and degenerative etiology, using only
unipolar clamp, achieved sinus rhythm in two years in only 40% of the patients.
Lazoupoulos et al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup> report a
series of 93 patients undergoing ablation concomitant to mitral surgery in which
both types of radiofrequency energy were used. After a 22-month follow-up period,
69% of the patients were in sinus rhythm, but the type of energy used was not a
determinant of success or failure. The great variation of therapeutic success (40%
to 89%) observed in the literature<sup>[<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r34" ref-type="bibr">34</xref>]</sup> is due to
different surgical populations, use of different forms of energy and heterogeneity
in the choice of lesion lines performed. Although unipolar radiofrequency energy is
considered useful in the confection of surgical ablation<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, some disadvantages in relation to bipolar clamps
are observed<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>, especially the
longer time necessary to perform the lesions and the impossibility of detecting its
transmurality.</p><p>In our Institution, the rheumatic etiology leads the indications of mitral valve
surgery. It is important to bear in mind that this is a risk factor for therapeutic
failure of AF ablation<sup>[<xref rid="r35" ref-type="bibr">35</xref>,<xref rid="r36" ref-type="bibr">36</xref>]</sup>. In this group of patients,
attention is drawn to the appearance of therapeutic failure due to right atrial
flutter in 10% of the patients. A better understanding of the pathophysiological
mechanisms of atrial flutter in the postoperative period may help to minimize this
therapeutic failure, possibly when considering the right atrial lines in all
patients, as discussed by Cox in his original study on the results of classic cut
and suture procedure.</p><sec><title>Limitations</title><p>Retrospective analysis with information collection in non-digitized medical
records. There is no institutional protocol for performing the surgical ablation
lines that were performed by several teams of different surgeons. Use of
different devices related to the surgeon's preference and availability in the
Institution. Unstructured follow-up care protocols for the management of
postoperative atrial fibrillation. Use of electrocardiogram and Holter (less
than 1 Holter/patient) only for the detection of AF.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Atrial fibrillation ablation surgery combined with a surgical approach of the
rheumatic mitral valve has been shown to be safe, with excellent survival and
stroke-free survival during the one-year follow-up period. The majority of patients
undergoing combined surgery were discharged from hospital at sinus rhythm and this
finding was a predictor of maintenance of sinus rhythm during the one-year follow-up
period. Increased left atrium and use of tissue ablation device by unipolar
radiofrequency were associated with a lower chance of being in sinus rhythm one year
after surgery.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EKC</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">ASC</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">AJOM</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">LSC</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">ETM</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">CW</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">ONB</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">AO</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or acquisition; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Instituto Nacional de Cardiologia (INC), Rio de
Janeiro, RJ, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>WM</given-names></name><name><surname>Blackshear</surname><given-names>JL</given-names></name><name><surname>Laupacis</surname><given-names>A</given-names></name><name><surname>Kronmal</surname><given-names>R</given-names></name><name><surname>Hart</surname><given-names>RG</given-names></name></person-group><article-title>Prevalence, age, distribution and gender of patients with atrial
fibrillation. Analysis and implications</article-title><source>Arch Intern Med</source><year>1995</year><volume>155</volume><issue>5</issue><fpage>469</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">7864703</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name><name><surname>Silbershatz</surname><given-names>H</given-names></name><name><surname>Kannel</surname><given-names>WB</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Impact of atrial fibrillation on the risk of death: the
Framinghan Heart Study</article-title><source>Circulation</source><year>1998</year><volume>98</volume><issue>10</issue><fpage>946</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">9737513</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Hylek</surname><given-names>EM</given-names></name><name><surname>Phillips</surname><given-names>KA</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Henault</surname><given-names>LE</given-names></name><name><surname>Selby</surname><given-names>JV</given-names></name><etal/></person-group><article-title>Prevalence of diagnosed atrial fibrillation in adults: national
implications for rhythm management and stroke prevention: the
AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)
Study</article-title><source>JAMA</source><year>2001</year><volume>285</volume><issue>18</issue><fpage>2370</fpage><lpage>2375</lpage><pub-id pub-id-type="pmid">11343485</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friberg</surname><given-names>J</given-names></name><name><surname>Buch</surname><given-names>P</given-names></name><name><surname>Scharling</surname><given-names>H</given-names></name><name><surname>Gadsbphioll</surname><given-names>N</given-names></name><name><surname>Jensen</surname><given-names>GB</given-names></name></person-group><article-title>Rising rates of hospital admissions for atrial
fibrillation</article-title><source>Epidemiology</source><year>2003</year><volume>14</volume><issue>6</issue><fpage>666</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">14569181</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colafranceschi</surname><given-names>AS</given-names></name><name><surname>Monteiro</surname><given-names>AJO</given-names></name><name><surname>Botelho</surname><given-names>ESL</given-names></name><name><surname>Canale</surname><given-names>LS</given-names></name><name><surname>Rabischoffky</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>IP</given-names></name><etal/></person-group><article-title>Cirurgia v&#x000ed;deo-assistida para a abla&#x000e7;&#x000e3;o de
fibrila&#x000e7;&#x000e3;o atrial isolada por radiofrequ&#x000ea;ncia
bipolar</article-title><source>Arq Bras Cardiol</source><year>2009</year><volume>93</volume><issue>4</issue><fpage>334</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">19936452</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornari</surname><given-names>LS</given-names></name><name><surname>Calderaro</surname><given-names>D</given-names></name><name><surname>Nassar</surname><given-names>IB</given-names></name><name><surname>Lauretti</surname><given-names>C</given-names></name><name><surname>Nakamura</surname><given-names>L</given-names></name><name><surname>Bagnatori</surname><given-names>R</given-names></name><etal/></person-group><article-title>Misuse of antithrombotic therapy in atrial fibrillation patients:
frequent, pervasive and persistent</article-title><source>J Thromb Thrombolysis</source><year>2007</year><volume>23</volume><issue>1</issue><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17186395</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappone</surname><given-names>C</given-names></name><name><surname>Rosario</surname><given-names>S</given-names></name><name><surname>Augello</surname><given-names>G</given-names></name><name><surname>Gallus</surname><given-names>G</given-names></name><name><surname>Vicedomini</surname><given-names>G</given-names></name><name><surname>Mazzone</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mortality, morbidity, and quality of life after circumferential
pulmonary vein ablation for atrial fibrillation: outcomes from a controlled
nonrandomized long-term study</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>42</volume><issue>2</issue><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">12875749</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Ad</surname><given-names>N</given-names></name><name><surname>Palazzo</surname><given-names>T</given-names></name><name><surname>Fitzpatrick</surname><given-names>S</given-names></name><name><surname>Suyderhoud</surname><given-names>JP</given-names></name><name><surname>DeGroot</surname><given-names>KW</given-names></name><etal/></person-group><article-title>Current status of the Maze procedure for the treatment of atrial
fibrillation</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2000</year><volume>12</volume><issue>1</issue><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">10746917</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Ad</surname><given-names>N</given-names></name></person-group><article-title>New surgical and catheter-based modifications of the Maze
procedure</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2000</year><volume>12</volume><issue>1</issue><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">10746926</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geidel</surname><given-names>S</given-names></name><name><surname>Ostermeyer</surname><given-names>J</given-names></name><name><surname>Lass</surname><given-names>M</given-names></name><name><surname>Boczor</surname><given-names>S</given-names></name><name><surname>Kuck</surname><given-names>KH</given-names></name></person-group><article-title>Surgical treatment of permanent atrial fibrillation during
cardiac surgery using monopolar and bipolar radiofrequency
ablation</article-title><source>Indian Pacing Electrophysiol J</source><year>2003</year><volume>3</volume><issue>3</issue><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16943907</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunning</surname><given-names>J</given-names></name><name><surname>Nagendran</surname><given-names>M</given-names></name><name><surname>Alfieri</surname><given-names>OR</given-names></name><name><surname>Elia</surname><given-names>S</given-names></name><name><surname>Kappetein</surname><given-names>AP</given-names></name><name><surname>Lockowandt</surname><given-names>U</given-names></name><etal/></person-group><article-title>Guideline for the surgical treatment of atrial
fibrillation</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>44</volume><issue>5</issue><fpage>777</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">23956274</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name></person-group><article-title>Atrial fibrillation I: a new classification
system</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><issue>6</issue><fpage>1686</fpage><lpage>1692</lpage><pub-id pub-id-type="pmid">14688672</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geidel</surname><given-names>S</given-names></name><name><surname>Ostermeyer</surname><given-names>J</given-names></name><name><surname>Lass</surname><given-names>M</given-names></name><name><surname>Boczor</surname><given-names>S</given-names></name><name><surname>Kuck</surname><given-names>KH</given-names></name></person-group><article-title>Surgical treatment of permanent atrial fibrillation during
cardiac surgery using monopolar and bipolar radiofrequency
ablation</article-title><source>Indian Pacing Electrophysiol J</source><year>2003</year><volume>3</volume><issue>3</issue><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16943907</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>D'Agostino</surname><given-names>HJ</given-names><suffix>Jr</suffix></name><name><surname>Stone</surname><given-names>CM</given-names></name><name><surname>Chang</surname><given-names>BC</given-names></name><name><surname>Cain</surname><given-names>ME</given-names></name><etal/></person-group><article-title>The surgical treatment of atrial fibrillation. III. Development
of a definitive surgical procedure</article-title><source>J Thorac Cardiovasc Surg</source><year>1991</year><volume>101</volume><issue>4</issue><fpage>569</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">2008095</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khargi</surname><given-names>K</given-names></name><name><surname>Hutten</surname><given-names>BA</given-names></name><name><surname>Lemke</surname><given-names>B</given-names></name><name><surname>Deneke</surname><given-names>T</given-names></name></person-group><article-title>Surgical treatment of atrial fibrillation; a systematic
review</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>27</volume><issue>2</issue><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15691679</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>S</given-names></name><name><surname>Medi</surname><given-names>C</given-names></name><name><surname>La Meir</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparing energy sources for surgical ablation of atrial
fibrillation: a Bayesian network meta-analysis of randomized, controlled
trials</article-title><source>Eur J Cardiothorac Surg</source><year>2015</year><volume>48</volume><issue>2</issue><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">25391388</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brick</surname><given-names>AV</given-names></name><name><surname>Braile</surname><given-names>DM</given-names></name></person-group><article-title>Surgical ablation of atrial fibrillation using energy
sources</article-title><source>Braz J Cardiovasc Surg</source><year>2015</year><volume>30</volume><issue>6</issue><fpage>636</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">26934404</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lins</surname><given-names>RMM</given-names></name><name><surname>Lima</surname><given-names>RC</given-names></name><name><surname>Silva</surname><given-names>FPV</given-names></name><name><surname>Menezes</surname><given-names>AM</given-names></name><name><surname>Salerno</surname><given-names>PR</given-names></name><name><surname>Th&#x000e9;</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Tratamento da fibrila&#x000e7;&#x000e3;o atrial por ultrassom,
durante corre&#x000e7;&#x000e3;o cir&#x000fa;rgica de doen&#x000e7;a valvar
card&#x000ed;aca</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>3</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">21103740</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bipolar radiofrequency ablation is useful for treating atrial
fibrillation combined with heart valve diseases</article-title><source>BMC Surg</source><year>2014</year><volume>14</volume><fpage>32</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">24884667</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canale</surname><given-names>LS</given-names></name><name><surname>Colafranceschi</surname><given-names>AS</given-names></name><name><surname>Monteiro</surname><given-names>AJO</given-names></name><name><surname>Marques</surname><given-names>BM</given-names></name><name><surname>Canale</surname><given-names>SC</given-names></name><name><surname>Koehler</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Tratamento cir&#x000fa;rgico de fibrila&#x000e7;&#x000e3;o atrial
utilizando abla&#x000e7;&#x000e3;o por radiofrequ&#x000ea;ncia bipolar em
doen&#x000e7;a mitral reum&#x000e1;tica</article-title><source>Rev Bras Cir Cardiovasc</source><year>2011</year><volume>26</volume><issue>4</issue><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">22358271</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brick</surname><given-names>AV</given-names></name><name><surname>Seixas</surname><given-names>T</given-names></name><name><surname>Portilho</surname><given-names>C</given-names></name><name><surname>Peres</surname><given-names>AK</given-names></name><name><surname>Vieira</surname><given-names>JJ</given-names><suffix>Jr</suffix></name><name><surname>Melo</surname><given-names>R</given-names><suffix>Neto</suffix></name><etal/></person-group><article-title>Tratamento intra-operat&#x000f3;rio da fibrila&#x000e7;&#x000e3;o
atrial cr&#x000f4;nica com ultra-som</article-title><source>Rev Bras Cir Cardiovasc</source><year>2001</year><volume>16</volume><issue>4</issue><fpage>337</fpage><lpage>349</lpage></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>CA</given-names><suffix>Filho</suffix></name><name><surname>Lisboa</surname><given-names>LA</given-names></name><name><surname>Dallan</surname><given-names>LA</given-names></name><name><surname>Spina</surname><given-names>GS</given-names></name><name><surname>Grinberg</surname><given-names>M</given-names></name><name><surname>Scanavacca</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effectiveness of the maze procedure using cooled-tip
radiofrequency ablation in patients with permanent atrial fibrillation and
rheumatic mitral valve disease</article-title><source>Circulation</source><year>2005</year><volume>112</volume><issue>9 Suppl</issue><fpage>I20</fpage><lpage>I25</lpage><pub-id pub-id-type="pmid">16159816</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weimar</surname><given-names>T</given-names></name><name><surname>Schena</surname><given-names>S</given-names></name><name><surname>Bailey</surname><given-names>MS</given-names></name><name><surname>Maniar</surname><given-names>HS</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Cox</surname><given-names>JL</given-names></name><etal/></person-group><article-title>The cox-maze procedure for lone atrial fibrillation: a
single-center experience over 2 decades</article-title><source>Circ Arrhythm Electrophysiol</source><year>2012</year><volume>5</volume><issue>1</issue><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">22095640</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earley</surname><given-names>MJ</given-names></name><name><surname>Schilling</surname><given-names>RJ</given-names></name></person-group><article-title>Catheter and surgical ablation of atrial
fibrillation</article-title><source>Heart</source><year>2006</year><volume>92</volume><issue>2</issue><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">16415203</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cjeh</surname><given-names>SA</given-names></name><name><surname>Tai</surname><given-names>CT</given-names></name></person-group><article-title>Catheter ablation of atrial fibrillation originating from the
non-pulmonary vein foci</article-title><source>J Cardiovasc Electrophysiol</source><year>2005</year><volume>16</volume><issue>2</issue><fpage>229</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">15720466</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breda</surname><given-names>JR</given-names></name><name><surname>Ragognette</surname><given-names>RG</given-names></name><name><surname>Breda</surname><given-names>ASCR</given-names></name><name><surname>Gurian</surname><given-names>DB</given-names></name><name><surname>Horiuti</surname><given-names>L</given-names></name><name><surname>Machado</surname><given-names>LN</given-names></name><etal/></person-group><article-title>Avalia&#x000e7;&#x000e3;o inicial da abla&#x000e7;&#x000e3;o
operat&#x000f3;ria biatrial por radiofrequ&#x000ea;ncia de
fibrila&#x000e7;&#x000e3;o atrial</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>1</issue><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">20563467</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>MA</given-names></name></person-group><source>Estudo experimental comparativo entre ultrassom e radiofrequ&#x000ea;ncia
na realiza&#x000e7;&#x000e3;o de linhas de abla&#x000e7;&#x000e3;o atriais por
via epic&#x000e1;rdica</source><comment>doutorado</comment><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Universidade Federal de S&#x000e3;o Paulo</publisher-name><year>2003</year><fpage>106p</fpage><lpage>106p</lpage></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breda</surname><given-names>JR</given-names></name><name><surname>Ribeiro</surname><given-names>CG</given-names></name></person-group><article-title>Surgical treatment of atrial fibrillation: integrative
review</article-title><source>Rev Bras Cir Cardiovas</source><year>2011</year><volume>26</volume><issue>3</issue><fpage>447</fpage><lpage>454</lpage></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Maruthappu</surname><given-names>M</given-names></name><name><surname>Nagendran</surname><given-names>M</given-names></name></person-group><article-title>How effective is unipolar radiofrequency ablation for atrial
fibrillation during concomitant cardiac surgery?</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2012</year><volume>14</volume><issue>6</issue><fpage>843</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">22419797</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>La Meir</surname><given-names>M</given-names></name><name><surname>Black</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>T</given-names></name></person-group><article-title>Surgical ablation for treatment of atrial fibrillation in cardiac
surgery: a cumulative meta-analysis of randomised controlled
trials</article-title><source>Heart</source><year>2014</year><volume>100</volume><issue>9</issue><fpage>722</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">24650881</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillinov</surname><given-names>AM</given-names></name><name><surname>Gelijns</surname><given-names>AC</given-names></name><name><surname>Parides</surname><given-names>MK</given-names></name><name><surname>DeRose</surname><given-names>JJ</given-names><suffix>Jr</suffix></name><name><surname>Moskowitz</surname><given-names>AJ</given-names></name><name><surname>Voisine</surname><given-names>P</given-names></name><etal/><collab>CTSN Investigators</collab></person-group><article-title>Surgical ablation of atrial fibrillation during mitral-valve
surgery</article-title><source>N Engl J Med</source><year>2015</year><volume>372</volume><issue>15</issue><fpage>1399</fpage><lpage>1409</lpage><pub-id pub-id-type="pmid">25853744</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinho-Gomes</surname><given-names>AC</given-names></name><name><surname>Amorim</surname><given-names>MJ</given-names></name><name><surname>Oliveira</surname><given-names>SM</given-names></name><name><surname>Azevedo</surname><given-names>L</given-names></name><name><surname>Almeida</surname><given-names>J</given-names></name><name><surname>Maciel</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Concomitant unipolar radiofrequency ablation of nonparoxysmal
atrial fibrillation in rheumatic and degenerative valve
disease</article-title><source>J Card Surg</source><year>2005</year><volume>30</volume><issue>1</issue><fpage>117</fpage><lpage>123</lpage></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazopoulos</surname><given-names>G</given-names></name><name><surname>Mihas</surname><given-names>C</given-names></name><name><surname>Manns-Kantartzis</surname><given-names>M</given-names></name><name><surname>Kantartzis</surname><given-names>M</given-names></name></person-group><article-title>Radiofrequency ablation for atrial fibrillation during
concomitant cardiac surgery. Midterm results</article-title><source>Herz</source><year>2014</year><volume>39</volume><issue>2</issue><fpage>206</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">23549757</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Nagendran</surname><given-names>M</given-names></name><name><surname>Maruthappu</surname><given-names>M</given-names></name></person-group><article-title>How effective is bipolar radiofrequency ablation for atrial
fibrillation during concomitant cardiac surgery?</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2012</year><volume>15</volume><issue>4</issue><fpage>741</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">22815321</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fayad</surname><given-names>G</given-names></name><name><surname>Le Tourneau</surname><given-names>T</given-names></name><name><surname>Modine</surname><given-names>T</given-names></name><name><surname>Azzaoui</surname><given-names>R</given-names></name><name><surname>Ennezat</surname><given-names>PV</given-names></name><name><surname>Decoene</surname><given-names>C</given-names></name><etal/></person-group><article-title>Endocardial radiofrequency ablation during mitral valve surgery:
effect on cardiac rhythm, atrial size, and function</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><issue>5</issue><fpage>1505</fpage><lpage>1511</lpage><pub-id pub-id-type="pmid">15854924</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MC</given-names></name><name><surname>Chang</surname><given-names>JP</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Clinical determinants of sinus conversion by radiofrequency maze
procedure for persistent atrial fibrillation in patients undergoing
concomitant mitral valvular surgery</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>11</issue><fpage>1553</fpage><lpage>1557</lpage><pub-id pub-id-type="pmid">16310439</pub-id></element-citation></ref></ref-list></back></article>